Biogen Inc. (BIIB)
NASDAQ · Healthcare
Biogen Inc. Shareholder Equity 2007–2025
Biogen Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Biogen Inc. shareholder equity as of December 31, 2025: 18.26B, a 9.22% increase year-over-year.
- Biogen Inc. shareholder equity for 2025 were 18.26B, a 9.22% increase from 2024.
- Biogen Inc. shareholder equity for 2024 were 16.72B, a 12.95% increase from 2023.
- Biogen Inc. shareholder equity for 2023 were 14.80B, a 10.46% increase from 2022.
- Biogen Inc. shareholder equity for 2022 were 13.40B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Biogen Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $18,257 |
| 2024 | $16,716 |
| 2023 | $14,799 |
| 2022 | $13,398 |
| 2021 | $10,896 |
| 2020 | $10,700 |
| 2019 | $13,343 |
| 2018 | $13,040 |
| 2017 | $12,613 |
| 2016 | $12,140 |
| 2015 | $9,373 |
| 2014 | $10,809 |
| 2013 | $8,620 |
| 2012 | $6,962 |
| 2011 | $6,425 |
Biogen Inc. Shareholder Equity — FAQ
Biogen Inc. (BIIB) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIIB's shareholder equity history?
The chart and table above show Biogen Inc.'s shareholder equity by year and by quarter, including the growth rate.